Responsibility
As a global leader in pain management, conducting business responsibly is a core part of our company’s strategy and culture. We provide transparent responsibility and sustainability reporting on our progress, and our performance is regularly rated by an independent agency according to environmental, social and governance (ESG) criteria. We join forces for sustainability and are committed to supporting the United Nations Sustainable Development Goals (SDGs).
Recent corporate responsibility activities
Corporate responsibility – 2022 in numbers
completion rate for training about our Code of Conduct, conflicts of interest and corporate responsibility by March 2023.
Grünenthal’s ESG risk rating for 2023 is in the top 2% of the pharmaceuticals sub-industry.
female share of employees in executive roles (2022 vs. 19% in 2018).
invested worldwide in awareness and accessibility initiatives in 2022.
visitors to our educational websites for pain management in 2022.
reduction in Scope 2 emissions (indirect CO2e emissions from acquired energy) in 2022.